Prab: CSV import

2024-03-06T04:38:29Z

CSV import

New page

[[File:5F-APINACA.png|thumb|{{PAGENAME}}]]<br>'''5F-APINACA''' (also known as '''5F-AKB-48''' or '''APINACA 5-fluoropentyl analog''') is a synthetic cannabinoid of the [[APINACA]] series. It was first identified in South Korea and is available for sale as a grey area research chemical through online vendors.

==Chemistry==
5F-APINACA is a synthetic cannabinoid that has similar properties to natural [[cannabinoids]] such as [[delta-9-tetrahydrocannabinol]] (THC). It is part of the [[APINACA]] series and is the 5-fluoropentyl analog of APINACA. The chemical formula of 5F-APINACA is C23H30FN3O.

==Pharmacology==
The pharmacology of 5F-APINACA is largely unknown. However, it is known to act as a potent [[agonist]] for the [[CB1 receptor]], which is the primary binding site of THC in the body. This suggests that 5F-APINACA may have similar psychoactive effects to THC, although this has not been confirmed in scientific studies.

==Legal Status==
The legal status of 5F-APINACA varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act. In Canada, it is a Schedule II substance under the Controlled Drugs and Substances Act.

==Health Risks==
The health risks associated with 5F-APINACA are not well understood due to the lack of scientific research. However, synthetic cannabinoids in general are known to be associated with a range of adverse effects, including [[psychosis]], seizures, and even death in extreme cases.

==See Also==
* [[Synthetic cannabinoids]]
* [[APINACA]]
* [[Cannabinoid receptor]]

[[Category:Synthetic cannabinoids]]
[[Category:Designer drugs]]
[[Category:Controlled substances]]
{{pharmacology-stub}}

5F-APINACA - Revision history

Prab: CSV import